UK introduces measures to reduce errors with methotrexate.
作者信息
Mayor Susan
出版信息
BMJ. 2003 Jul 12;327(7406):70. doi: 10.1136/bmj.327.7406.70.
Abstract
摘要
相似文献
1
UK introduces measures to reduce errors with methotrexate.
BMJ. 2003 Jul 12;327(7406):70. doi: 10.1136/bmj.327.7406.70.
2
Ulcerations due to methotrexate toxicity in a psoriasis patient.
An Bras Dermatol. 2016 May-Jun;91(3):375-7. doi: 10.1590/abd1806-4841.20163960.
3
[Accidental shortening time of high dose methotrexate infusion: case report and literature review].
Ann Biol Clin (Paris). 2013 Mar-Apr;71(2):219-22. doi: 10.1684/abc.2013.0803.
4
[Use of methotrexate for treatment of corticosteroid-dependent asthma].
Pneumonol Alergol Pol. 1997;65(3-4):225-30.
5
Mucocutaneous ulcerations secondary to methotrexate.
Cutis. 2008 May;81(5):413-6.
6
Weekly methotrexate: harmful to exposed embryos.
Prescrire Int. 2015 Apr;24(159):98.
7
[Fatal bone marrow aplasia after the 1st injection of methotrexate in a woman with Crohn's disease].
Gastroenterol Clin Biol. 1999 Oct;23(10):1102-3.
8
[Correct use of methotrexate].
Ned Tijdschr Geneeskd. 2009;153:A696.
9
Systemic therapy of psoriasis: methotrexate.
Bratisl Lek Listy. 2011;112(7):390-4.
10
Reported medication errors associated with methotrexate.
Am J Health Syst Pharm. 2004 Jul 1;61(13):1380-4. doi: 10.1093/ajhp/61.13.1380.
Zotero 插件